About Gene List

PF3D7_1225800 (UBA1)

Genome location: Pf3D7_12_v3:1,044,957..1,050,130(+)

Genome classification: Core

Function and Localization

Product Description: ubiquitin-activating enzyme E1

SignalP Peptide: N/A

# Transmembrane Domains: 0

EC Numbers: 6.2.1.45 (E1 ubiquitin-activating enzyme);6.3.2.19 (Transferred entry: 2.3.2.23, 2.3.2.27 and 6.2.1.45)

Curated GO (PlasmoDB):

Type GO Term Name
Component GO:0005737 cytoplasm
Component GO:0005634 nucleus
Function GO:0004839 ubiquitin activating enzyme activity
Process GO:0006974 cellular response to DNA damage stimulus
Process GO:0032446 protein modification by small protein conjugation
Process GO:0016567 protein ubiquitination
Process GO:0009410 response to xenobiotic stimulus
Process GO:0006511 ubiquitin-dependent protein catabolic process

Expression by stage (LR - Le Roch et al., and MCA - Malaria Cell Atlas):

Stage LR class MCA mean MCA prop. zeros
Sporozoite expressed N/A N/A
Ring expressed 0.71 0.67
Trophozoite expressed 1.36 0.36
Schizont expressed 0.71 0.63
Gametocyte expressed 0.68 0.63

More info:

Resistome Mutations

Old (Pf3D7v3) Gene ID: PF3D7_1225800

Resistome Missense Mutations: None

Resistome Compounds with Missense Mutations: None

Resistome # Samples with Disruptive Mutations: 0 (0 missense, 0 "interesting" missense)

Essentiality (ABS)

Zhang Phenotype: Non - Mutable in CDS

MIS: 0.121 | MFS: -2.922 | #Insertions: 0

PlasmoGEM Phenotype: Dispensable (Pb ortholog: PBANKA_1440700)

  • Relative Growth Rate: 0.99 ± 0.46
  • Confidence: 2.93

RMgmDB ABS Phenotype: Different from wild type (Pb ortholog: PBANKA_1440700)

Modification: Disrupted | RMgm-3944

More info: PhenoPlasm Link

Binding Evidence

AlphaFill Uniprot ID: Q8I5F9

"Best" AlphaFill ligand hit: AMP (adenosine monophosphate, Local RMSD=0.19) with 4NNJ (Global RMSD=5.93)

BRENDA EC Inhibitors:

EC # Name EC Inhibitors
6.2.1.45 E1 ubiquitin-activating enzyme LMO2PYR-41AtMUB3largazoletrichostatin Aginsenoside Reginsenoside Rg1[ubiquitin carrier protein Ubc4]-L-cysteine5'-[[(L-cysteinylglycylglycyl)sulfamoyl]amino]-5'-deoxyadenosine1-(3-chloro-4-fluorophenyl)-4-[(5-nitro-2-furyl)methylene]-3,5-pyrazolidinedione4[4-(5-nitro-furan-2-ylmethylene)-3,5-dioxo-pyrazolidin-1-yl]-benzoic acid ethyl ester(5R,8S)-11-ethenyl-5-methyl-8-(propan-2-yl)-10-oxa-3,17-dithia-7,14,19,20-tetraazatricyclo[14.2.1.1~2,5~]icosa-1(18),2(20),16(19)-triene-6,9,13-trione...
6.3.2.19 ubiquitin-protein ligase No BRENDA inhibitors

Orthology to BindingDB Entries:

UniProt Protein Name Species Homology Source BindingDB Ligands
A0AVT1 Ubiquitin-like modifier-activating enzyme 6 Homo sapiens HOGENOM, OrthoDB US9593121, 1-01US9593121, I-02US9593121, I-03US9593121, I-04...
P41226 Ubiquitin-like modifier-activating enzyme 7 Homo sapiens HOGENOM, OrthoDB CHEMBL2017005
P22314 Ubiquitin-like modifier-activating enzyme 1 Homo sapiens HOGENOM, OMA, OrthoDB Compound ICompound ICompound IUS9796725, Compound I-001...
Q9UBT2 SUMO-activating enzyme subunit 2 OrthoDB US9796725, Compound I-001US9796725, Compound I-098US9796725, Compound I-003US9796725, Compound I-004...
Q8TBC4 NEDD8-activating enzyme E1 catalytic subunit OrthoDB MITOXANTRONEPevonedistatCHEMBL4878088CHEMBL4865086...

Orthology Information

Ortholog Group (OrthoMCL): OG6_100444

Most Similar Human Ortholog: P22314

TM-align score: 0.92 | RMSD: 2.35

Seq Identity: 0.36 | Length: 1013 / 1140

All Human Orthologs (OrthoMCL):

Gene ID Description
ENSG00000033178 ubiquitin like modifier activating enzyme 6
ENSG00000130985 ubiquitin like modifier activating enzyme 1
ENSG00000145241 centromere protein C
ENSG00000182179 ubiquitin like modifier activating enzyme 7

Protein Information

Protein Length: 1140 | Molecular Weight (kDa): 131.778

UniProt ID(s): Q8I5F9

PDB ID(s): None

Isoelectric Point: 5.51

Protein Domain Annotations:

Source Family ID Description
InterPro IPR000011 Ubiquitin/SUMO-activating enzyme E1
InterPro IPR000594 THIF-type NAD/FAD binding fold
InterPro IPR018965 Ubiquitin-activating enzyme E1, C-terminal
InterPro IPR019572 Ubiquitin-activating enzyme, catalytic cysteine domain
InterPro IPR032418 Ubiquitin-activating enzyme E1, FCCH domain
InterPro IPR032420 Ubiquitin-activating enzyme E1, four-helix bundle
InterPro IPR033127 Ubiquitin-activating enzyme E1, Cys active site
InterPro IPR035985 Ubiquitin-activating enzyme
PFam PF00899 THIF-type NAD/FAD binding fold
PFam PF09358 Ubiquitin-activating enzyme E1, C-terminal
PFam PF10585 Ubiquitin-activating enzyme, catalytic cysteine domain
PFam PF16190 Ubiquitin-activating enzyme E1, FCCH domain
PFam PF16191 Ubiquitin-activating enzyme E1, four-helix bundle
Superfamily SSF69572 Ubiquitin-activating enzyme

Genetic Variation

MalariaGEN Pf7 (worldwide samples) # unique SNV/indels:

Homozygous genotype calls only

variant type common rare doubleton singleton
synonymous 10 28 26 58
disruptive 6 47 28 132
missense 6 46 27 118

Any inclusion in genotype call

variant type common rare doubleton singleton
synonymous 15 80 39 62
disruptive 15 148 88 222
missense 11 125 74 159

PlasmoDB Total SNPs: 223

Non-coding: 180 | Synonymous: 34 | Nonsynonymous: 9 | Stop Codon: 0

Associated Publications

PMID Title Authors DOI/Link
12368864 Genome sequence of the human malaria parasite Plasmodium falciparum. Gardner MJ, Hall N, ..., Barrell B 10.1038/nature01097
16267556 A protein interaction network of the malaria parasite Plasmodium falciparum. LaCount DJ, Vignali M, ..., Hughes RE 10.1038/nature04104
22912882 Characterization of the ubiquitylating components of the human malaria parasite'sprotein degradation pathway. Chung DW, Ponts N, ..., Le Roch KG 10.1371/journal.pone.0043477